Study of Efficacy on NT-proBNP of Recombinant Human Neuregulin-1 in Chronic Heart Failure Patients
Status:
Terminated
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
Multi-center, randomized, double-blind , placebo parallel controlled, standard therapy based
phase III clinical trial, to evaluate the efficacy of recombinant human neuregulin-1 on serum
NT-proBNP, as well as safety in patients with chronic heart failure.